About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 526837, 7 pages
http://dx.doi.org/10.1155/2013/526837
Research Article

CYP3A5*3 and C3435T MDR1 Polymorphisms in Prognostication of Drug-Resistant Epilepsy in Children and Adolescents

1Department of Neuropediatrics, Medical University of Silesia, 16 Medykow Street, 40-752 Katowice, Poland
2Department of Human Anatomy, Medical University of Silesia, 18 Medykow Street, 40-752 Katowice, Poland
3Department of Biochemistry and Medical Genetics, School of Health Care, Medical University of Silesia, 18 Medykow Street, 40-752 Katowice, Poland
4Department of General and Molecular Biology and Genetics, Medical University of Silesia, 18 Medykow Street, 40-752 Katowice, Poland
5CoE Research and Teaching of Molecular Biology of Matrix and Nanotechnology, Network of CoE BioMedTech Silesia, 40-752 Katowice, Poland

Received 30 April 2013; Accepted 25 June 2013

Academic Editor: Luca Cucullo

Copyright © 2013 Ewa Emich-Widera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ewa Emich-Widera, Wirginia Likus, Beata Kazek, et al., “CYP3A5*3 and C3435T MDR1 Polymorphisms in Prognostication of Drug-Resistant Epilepsy in Children and Adolescents,” BioMed Research International, vol. 2013, Article ID 526837, 7 pages, 2013. doi:10.1155/2013/526837